Log in to save to my catalogue

Clinically accessible amplitude-based multiplex ddPCR assay for tryptase genotyping

Clinically accessible amplitude-based multiplex ddPCR assay for tryptase genotyping

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_733cbf0add714b448e0c4caa7df11628

Clinically accessible amplitude-based multiplex ddPCR assay for tryptase genotyping

About this item

Full title

Clinically accessible amplitude-based multiplex ddPCR assay for tryptase genotyping

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2024-01, Vol.14 (1), p.2416-8, Article 2416

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Hereditary α tryptasemia (HαT) is an autosomal dominant trait characterized by increased
TPSAB1
copy number (CN) encoding α-tryptase. The determination of HαT is being discussed as an important biomarker to be included in risk assessment models and future diagnostic algorithms for patients with mastocytosis and anaphylaxis. Due to the complex...

Alternative Titles

Full title

Clinically accessible amplitude-based multiplex ddPCR assay for tryptase genotyping

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_733cbf0add714b448e0c4caa7df11628

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_733cbf0add714b448e0c4caa7df11628

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-024-52983-8

How to access this item